医学信息Issue(23)：50-50,1.
西黄丸联合介入治疗对中晚期肝癌的临床观察
Clinical Effect Observation of Xihuangwan Combined with Interventional Therapy on Treatment of Advanced Hepatocellular Carcinoma
刘永利 1王晓燕 1郭滨 1崔洪霞 1嘉立娟1
作者信息
- 1. 滨州医学院附属滨州中心医院结防院肿瘤二科，山东 滨州 256600
- 折叠
摘要
Abstract
Objective To observe the clinical ef ect of Xihuangwan combined with interventional therapy on treatment of advanced hepatocel ular carcinoma.Methods 87cases patients with advanced hepatocel ular carcinoma were randomly divided into Combination group (49 cases)and Control group (38 cases).Both of 2 groups were treated with interventional therapy,and Combination group added Xihuangwan.Observed the clinical ef ect of 2 groups and changes of tumor marker CA19-9 level.Results The total ef ective rate of Combination group (57.1%)was higher than that of control group (37.5%),the dif erence was statistical y significant ( <0.05). The CA19-9 level ef ective rate of Combination group (63.3%)was higher than that of control group(36.8%),the dif erence was statistical y significant ( <0.05).Conclusion Xihuangwan combined with interventional therapy on treatment of advanced hepatocel ular carcinoma can significantly improve the clinical symptoms, reduced tumor marker levels and restore the body's normal function in patients with clinical value.关键词
肝癌/中晚期/西黄丸/介入治疗Key words
Hepatocel ular carcinoma/Advanced/Xihuangwan/Interventional therapy引用本文复制引用
刘永利,王晓燕,郭滨,崔洪霞,嘉立娟..西黄丸联合介入治疗对中晚期肝癌的临床观察[J].医学信息,2015,(23):50-50,1.
